Romão EA, Moysés Neto M, Teixeira SR, Muglia VF, Vieira-Neto OM, Dantas M. Renal and extrarenal manifestations of autosomal dominant polycystic kidney disease. Braz J Med Biol Res.. 2006;39:533-8.

Torra R, Nicolau C, Badenas C. Abdominal aortic aneurysms and autosomal dominant polycystic kidney disease. J Am Soc Nephrol.. 1996;7:2483-6.

Takagi H, Umemoto T. Matrix metalloproteinases synthesized in autosomal dominant polycystic kidney disease play a role in development of a concurrent abdominal aortic aneurysm. Med Hypotheses.. 2005;64:778-81.

Picazo M, Cuxart M, Nadal C, Sans R. Aneurisma de la arteria esplénica y disección arterial femoro-ilíaca en la poliquistosis renal autosómica dominante. Nefrología.. 2007;27:223-4.

Paynter HE, Parnham A, Feest TG, Dudley CR. Thoracic aortic dissection complicating autosomal dominant polycystic kidney disease. Nephrol Dial Transplant.. 1997;12:1711-3.

Bobrie G, Brunet-Bourgin F, Alamowitch S. Spontaneous artery dissection: is it part of spectrum of autossomal dominant polycystic kidney disease?. Nephrol Dial Transplant.. 1998;13:2138-41.

Schrier RW, Belz MM, Johnson AM. Repeat imaging for intracranial aneurysms in patients with autosomal dominant polycystic kidney disease with initially negative studies: a prospective ten-year follow-up. J Am Soc Nephrol.. 2004;15:1023-8.

Pirson Y, Chauveau D, Torres V. Management of cerebral aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol.. 2002;13:269-76.

Somlo S, Rutecki G, Giuffra LA, Reeders ST, Cugino A, Whittier FC. A kindred exhibiting cosegregation of an overlap connective tissue disorder and the chromosome 16 linked form of autosomal dominant polycystic kidney disease. J Am Soc Nephrol.. 1993;6:1371-8.

Hobeika MJ, Thompson RW, Muhs BE, Brooks PC, Gagne PJ. Matrix metalloproteinases in peripheral vascular disease. J Vasc Surg.. 2007;45:849-57.